A full four year MRC iCASE studentship (one year MSc in Interdisciplinary Biomedical Research followed by a three-year PhD) is available at Warwick Medical School in collaboration with Boehringer Ingelheim to start in September 2019. Funding for an eligible applicant will covers fee, annual stipend of approximately £15,040 and an annual research training support grant for consumables of £2,500-£5,000. Applicants should have a good undergraduate degree (2i or above) in statistics or a related discipline.
Applications can be made via the website given below. The closing date for applications is 14 February 2019.
Project title: Innovative statistical methods for clinical trial pathways supporting regulatory drug approval
Warwick supervisor: Professor Nigel Stallard Boehringer Ingelheim supervisor: Dr Cornelia Ursula Kunz
Project summary: In collaboration with Boehringer Ingelheim, this PhD project will address important questions in the statistical design of clinical trials conducted to support the regulatory approval of new drugs. The project will involve modelling of decision-making and optimal design approaches for clinical trials, including the use of flexible innovative trial designs and the incorporation of external historical or concurrent data in the evidence base used to support regulatory approval. Statistical techniques involved will include the control of frequentist error rates, Bayesian and decision-modelling methods.
Full details, including eligibility requirements and a link to the online application form, are available at https://warwick.ac.uk/fac/sci/